Start Date
January 7, 2019
Primary Completion Date
May 8, 2019
Study Completion Date
May 8, 2019
Acitretin
Acitretin will be provided to participants in the formulation Soriatane. Soriatane doses are oral tablets taken daily by the participant. Participants will then receive 35mg of oral acitretin (Soriatane) daily for 8 weeks during the intervention phase. Participants will be asked to return two months after completion of the acitretin course for clinical follow-up and additional phlebotomy for laboratory testing.
Lead Sponsor
Ottawa Hospital Research Institute
OTHER